NURS FPX 8004 Assessment 2 Professional Practice Plan

Professional Practice Plan

Student name

Capella University

NURS-FPX8004

Professor Name

Submission Date

Professional Practice Plan

Pulmonary hypertension (PH) remains a top priority issue at the practice site, which is a specialty hospital in the South Eastern region of the United States of America that serves a diverse and often underserved population. Because early signs of fatigue and shortness of breath are falsely interpreted as the much more common diseases of asthma and heart failure, patients typically present with end-stage disease when the disease is of significance and the endpoint is lung failure and early death (Executive Nurse, personal communication August 15, 2025). The misdiagnoses contribute to delays to referral to the site’s specialty clinics, suggesting a disconnect between evidence-based practice recommendations for early intervention and organizational delivery of care. Internal chart reviews have identified inconsistencies with symptom onset documentation, unpredictable timing of echocardiographic testing, and delays in PH specialist referral (Executive Nurse, personal communication, August 15, 2025). Within the practice setting, there are also delays due to long waits for specialty referrals, insurance restrictions, and limited provider knowledge, putting the organization far below standards for timely and fair PH treatment in the community.

The delays are expensive. Lost opportunities in early diagnosis are associated with increased patient and family burden of symptoms, reduced functional ability, and the risk of admission to the hospital. For the simulation practice site, the problems are expensive, resource intensive for the inpatient setting, and a risk to compliance with the expectations related to the quality and patient safety regulation (Executive Nurse, personal communication, August 15, 2025). To address the practice gap, a quality improvement initiative that strives to strengthen referral channels, add to provider education, and leverage organizational resources is essential. By developing better results, moving closer to the national standards, and following the mission of delivering safe, effective, and patient-centered care, the practice site will help to improve results, thereby increasing its alignment with the national standards.

Problem Statement

Inability to access care contributes to the delay in identifying and referring patients with pulmonary hypertension at the practice setting. This delay leads to a late diagnosis and poorer outcomes (Executive Nurse, personal communication, August 15, 2025). Introducing a quality improvement initiative to reduce time between symptom presentation and specialty referral at least 25% over six months will help provide care that meets national standards and improves patient outcomes.

Thesis Statement

The quality improvement initiative, addressing the problem of inaccessibility to PH care and delayed diagnosis, will improve provider education, streamline referral procedures, and utilize interprofessional collaboration. The project will reduce the delay in diagnoses, access to specialty care, and patient-based outcomes of individuals with pulmonary hypertension.

Population

The patient population in the practice site is predominately adult patients aged 40 to 80 years, who are evaluated and treated due to pulmonary hypertension, and related cardiopulmonary diseases. Some have had advanced disease at presentation because of late onset of the early respiratory signs dyspnea, fatigue, and exercise intolerance, and some have associated comorbidities such as heart failure, chronic obstructive pulmonary disease (COPD), systemic hypertension, or connective tissue disease (Executive Nurse, personal communication, Aug. 15, 2025). Primary population is patients undergoing echocardiogram, right heart catheterization, and pulmonary function test for diagnostics and/or follow-up of PH, and secondary population is the family caregivers centrally involved in care coordination, adherence to treatment, and decision making (Executive Nurse, personal communication, August 15, 2025). Patients who are not diagnosed and treated with PH would exclude from the enrollment, as well as those who were treated only with non-pulmonary cardiac conditions (Oldroyd and Bhardwaj, 2024). The population is a socioeconomically diverse and mixed group with many barriers commonly manifested through transportation problems, a lack of insurance, and access to specialty care providers, which makes them highly salient to a quality improvement intervention to ensure timely diagnosis and referral cascades.

Stakeholders

Practice site stakeholders are a huge category of professionals who directly or indirectly influence PH management. Primary clinical stakeholders will include cardiologists, pulmonologists, physicians, and nurse practitioners who have the duty of identifying initial symptoms, administering diagnostic tests, and referring patients to PH specialists. The functions of nurses, respiratory therapists, and pharmacists are to teach patients, administer drugs, and monitor adherence to treatment (Gillmeyer et al., 2022). While case managers and social workers play a crucial role in ensuring that their clients have access to care, navigating the legal exceptions to mandatory referrals, insurance challenges, and transportation concerns that often delay access to care (Hudno et al., 2024). The role of administrative level quality improvement leaders and management is to provide resources, monitor performance and bring the program into compliance with regulation. Finally but not the least, the main stakeholder who directly encounters delayed diagnosis and fractured care is patients and families.

All sets of stakeholders will play their part in generating engagement and buy-in. Providers will also focus on clinical outcomes and the impact that standardized processes may have on reducing diagnostic delays. In the case of the allied health and nursing staff, the emphasis will reveal the opportunity to improve the working process and improve teamwork (Laurisz et al., 2023). Administrative managers will be encouraged by demonstrating how the PH gap relates to national quality indicators, reduces hospitalization costs, and provides a boost to the institution’s reputation. Education and communication that will empower patients and families to recognize symptoms in time and promote appropriate referral will be motivating.

The strategy to achieve cooperation and collaboration will involve the introduction of internal and national data eloquently demonstrating the risks of early diagnosis of PH and the advantages of early interventions. To support unit-level implementation of practices, we will develop a coalition of clinical champions among physicians and nurses (Petkovic et al., 2023). Continuous interdisciplinary conferences will allow ample space to each other and may aid in leadership via aligning the project with quality-, safety-, and fiscal-outcomes. By factoring in the perspectives of patients on the initiation and evaluation of the initiative, it will be possible to ensure that the project remains patient-oriented and culturally sensitive, which will contribute to an improved degree of commitment among stakeholders and increase its long-term sustainability.

PICOT Question Development

In adult patients, aged 40 to 80 years, presenting with pulmonary hypertension (P), how does implementing an early recognition and streamlined referral pathway to PH specialists (I), compared with the current standard referral process (C), affect time to diagnosis, initiation of treatment, and overall patient outcomes (O) within six months (T)?

• P (Population): Adult patients, aged 40 to 80 years, presenting with pulmonary hypertension
• I (Intervention): Implementation of an early recognition and streamlined referral pathway to PH specialists
• C (Comparison): Current standard referral process
• (Outcome): Time to diagnosis, initiation of treatment, and overall patient outcomes
• T (Time): 6 months

Using the PICOT framework, the quality improvement initiative will reduce delayed diagnosis and disparities in access to treatment of pulmonary hypertension at the specialty hospital in the Southeastern part of the United States. An organized referral route will replace the current haphazard mechanisms that contribute to late presentation. The pathway includes provider education, identifiable referral criteria, and the effective engagement of PH specialists. Within six months, the project will gauge time to diagnosis, time to start therapy and evidence-based care compliance. The program aims to enhance patient outcomes, delay disease progression, and expand delivery of timely and patient-centered PH care through better referral equity and consistency.

Conclusion

Addressing the consequences of delays in pulmonary hypertension diagnosis and disproportionate access to specialty care requires proper management of the issue, which will improve the outcomes within the practice setting. The proposed project will tend to address existing gaps in current practice by standardizing referral procedures, enhancing provider education and coordination, and aligning existing practices with evidence-based practice guidelines. When implemented effectively, it has the potential to improve patient outcomes, reduce inequalities, and enable more efficient use of healthcare resources. On balance, the initiative enhances organizational commitment to delivering timely, just, and patient-centered care to people with pulmonary hypertension.